Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma

By John K. Lin, MD; Lori S. Muffly, MS, MD; Michael A. Spinner, MD; James I. Barnes, MS, MD; Douglas K. Owens, MD; Jeremy D. Goldhaber-Fiebert, PhD